“The present situation has exposed some structural weaknesses while in the EU’s medicines source chain along with a significant dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that supply chain issues be resolved within an EU pharmaceutical system anticipated being lau